Eli Lilly investors shouldnt sweat rival Novo Nordisk having the first obes...
Eli Lilly investors shouldnt sweat rival Novo Nordisk having the first obesity pill on sale ## Market Reacts Unevenly to Obesity Drug Landscape Shift: Novo Nordisk Gains, Lilly Experiences Minor Dip The competitive landscape of the burgeoning obesity treatment market experienced a notable shift... read more »
27-year-old boosted his income from $50,000 to $432,000 at Amazon in 5 year...
27-year-old boosted his income from $50,000 to $432,000 at Amazon in 5 yearsit allowed him to quit and start his own business ## From Amazon Employee to Entrepreneur: One Man’s Strategic Rise and Departure Nabeel Khan’s career trajectory offers a compelling case study in strategic... read more »
Paramount guarantees Larry Ellison backing in amended WBD bid
Paramount guarantees Larry Ellison backing in amended WBD bid ## Paramount Stands Firm on Warner Bros. Discovery Merger Proposal Amidst Scrutiny **New York, NY** – Paramount Global has reaffirmed its commitment to its existing merger proposal with Warner Bros. Discovery (WBD), signaling... read more »
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk **Novo Nordisk Secures FDA Approval for Oral Obesity Treatment, Pioneering New Frontier in Weight Management** The U.S. Food and Drug Administration (FDA) has granted approval to Novo Nordisk for its oral formulation of a... read more »
